Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company operates through the following business divisions: New drug, and Medical materials. Its products include drugs for osteoporosis, arthritis, periodontal disease and cancer, functional food ingredients, dental bone graft materials, dental membrane, and dental supplies. The company was founded on December 8, 1998 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company